Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its protected piperazine structure with a dimethylcarbamoyl group enables selective reactions in multi-step organic syntheses, especially in the production of central nervous system agents and kinase inhibitors. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its stereochemical stability and functional group compatibility.